Diabetic Retinal Disease Rates Narrow by Diabetes Type

• by Andrea Surnit

• April 15, 2026

Diabetes and the Metabolic Syndrome as Drivers of Neurodegeneration: Convergent Mechanisms Linking Peripheral Neuropathy and Dementia

• by Masha G. Savelieff, David L. Bennett, Troels S. Jensen, Eva L. Feldman

• July 7, 2026

Investigational Drug Shows Potentialin Phase 3 Obesity Trial

In a 76-week randomized trial, patients with obesity without diabetes who received survodutide achieved greater weight loss and favorable changes in several metabolic measures compared with those who received placebo.

• by Andrea Surnit

• June 10, 2026

• 4 min

NNS beverages may match water in weight control

Adults assigned to nonnutritive sweetened beverages or water maintained weight reductions through 104 weeks, with no statistically significant difference between groups.

• by Andrea Surnit

• October 6, 2026

• 4 min